FDA Inspection 848700 — Rising Pharmaceuticals, Inc.
The FDA completed an inspection of Rising Pharmaceuticals, Inc. on Sep 16, 2013 in Saddle Brook, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 16, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Saddle Brook, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 15838 | 21 CFR 111.70(d) | Specifications - labels, packaging |
| 15839 | 21 CFR 111.70(e) | Specifications - identity, purity, strength, composition |
| 15863 | 21 CFR 111.75(a)(2)(ii)(B) | Component - certificate of analysis |